GCK, glucokinase, 2645

N. diseases: 210; N. variants: 182
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE A novel glucokinase gene mutation and its effect on glycemic/C-peptide fluctuations in a patient with maturity-onset diabetes of the young type 2. 20015564 2010
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease CTD_human Identification of 9-cis-retinoic acid as a pancreas-specific autacoid that attenuates glucose-stimulated insulin secretion. 21115832 2010
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR Glucokinase diabetes in 103 families from a country-based study in the Czech Republic: geographically restricted distribution of two prevalent GCK mutations. 20337973 2010
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease MGD Considering the lack of knowledge about the pathomorphology of maturity-onset diabetes of the young type 2 (MODY 2), this glucokinase mutant model of reduced total islet and total beta-cell volume provides the opportunity to elucidate the impact of a defective glucokinase on development and maintenance of beta-cell mass and its relevance in MODY 2 patients. 19952346 2010
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. 19790256 2009
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Biochemical characterization of MODY2 glucokinase variants V62M and G72R reveals reduced enzymatic activities relative to wild type. 19187021 2009
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease UNIPROT Opposite clinical phenotypes of glucokinase disease: Description of a novel activating mutation and contiguous inactivating mutations in human glucokinase (GCK) gene. 19884385 2009
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. 19790256 2009
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE We screened exons 7, 8 and 9, which are specific for pancreatic glucokinase, for mutations at positions 682A>G, p.T228A; 895G>C, p.G299R, and 1148C>A, p.S383X, respectively, in 250 subjects (100 patients suspected to have MODY2 and 150 healthy controls without family history of diabetes mellitus). 19551638 2009
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Mild fasting hyperglycemia in children: high rate of glucokinase mutations and some risk of developing type 1 diabetes mellitus. 19309449 2009
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families. 19564454 2009
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Human Splicing Finder: an online bioinformatics tool to predict splicing signals. 19339519 2009
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE Maturity-onset diabetes of the young, type 2 (MODY2) is caused by mutations in the glucokinase gene (GCK). 18399931 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease UNIPROT In this work, we describe the biochemical characterization of six missense glucokinase mutations associated with MODY2 from Spanish patients, namely, Y61S, V182L, C233R, E265K, A379V, and K420E. 18322640 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease BEFREE Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients. 18248649 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2). 18411240 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations (MODY2). 18411240 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE In this work, we describe the biochemical characterization of six missense glucokinase mutations associated with MODY2 from Spanish patients, namely, Y61S, V182L, C233R, E265K, A379V, and K420E. 18322640 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy. 18382660 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease BEFREE GCK mutations are known as a pathogenic cause of maturity-onset diabetes of the young type 2 (MODY2). 18271687 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy. 18382660 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 CausalMutation disease CLINVAR Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry. 18399931 2008
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease CLINVAR Six novel mutations in the GCK gene in MODY patients. 17204055 2007
Diabetes mellitus autosomal dominant type II (disorder)
1.000 GeneticVariation disease UNIPROT Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain. 17573900 2007
Diabetes mellitus autosomal dominant type II (disorder)
1.000 Biomarker disease MGD Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations. 17353190 2007